Flavonoids from seabuckthorn protect endothelial cells (EA.hy926) from oxidized low-density lipoprotein induced injuries via regulation of LOX-1 and eNOS expression

Journal of Cardiovascular Pharmacology

Volumn 48, Issue 1, 2006, Pages 834-841

  Bao, Meihua ^a   Lou, Yijia ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

EA.hy926; eNOS; Flavonoids from seabuckthorn; LOX 1; Superoxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLAVONOID; HIPPOPHAE RHAMNOIDES EXTRACT; ISORHAMNETIN; LACTATE DEHYDROGENASE; MESSENGER RNA; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; QUERCETIN; SUPEROXIDE DISMUTASE;

ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL DEATH; CELL VIABILITY; CHINESE MEDICINE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENDOTHELIUM CELL; ENZYME ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOPHAE RHAMNOIDES; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIPID OXIDATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRADITIONAL MEDICINE;

BIPHENYL COMPOUNDS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOTHELIAL CELLS; FLAVONOIDS; FLAVONOLS; FREE RADICAL SCAVENGERS; GENE EXPRESSION; HIPPOPHAE; HUMANS; HYDRAZINES; IMMUNOHISTOCHEMISTRY; L-LACTATE DEHYDROGENASE; LIPOPROTEINS, LDL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; QUERCETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCAVENGER RECEPTORS, CLASS E; SUPEROXIDE DISMUTASE;

EID: 33747757930     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000232064.64837.67     Document Type: Article

References (46)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Witztum JL, Steinberg D. Role of oxidized low-density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
3. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
4. Jacobson TA. Statin safety: lessons from new drug applications for marketed statins. Am J Cardiol. 2006;97:S44-S51.
5. Elliott Middleton JR, Kandaswami C, Theoharis C, et al. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000;52:673-751.
6. Beretz A, Anton R, Stoclet JC. Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase. Experientia. 1978;34:1054-1055.
7. Ulbricht TL, Southgate DA. Coronary heart disease: seven dietary factors. Lancet. 1991;338:985-992.
8. Duarte J, Andriambeloson E, Diebolt M, et al. Wine polyphenols stimulate superoxide anion production to promote calcium signaling and endothelial dependent vasodilation. Physiol Res. 2004;53:595-602.
9. Zhu Fu, Hu C. Effects of total flavonoids of Hippophae rhamnoides on intracellular free calcium in vascular smooth muscle cells of spontaneously hypertensive rats. Chin J New Drugs Clin Rem. 2004;23:500-503.
10. Ganju L, Padwad Y, Singh R, et al. Anti-inflammatory activity of Seabuckthorn (Hippophae rhamnoides) leaves. Int Immunopharmacol. 2005;5:1675-1684.
11. Goel HC, Gupta D, Gupta S, et al. Protection of mitochondrial system by Hippophae rhamnoides L. against radiation-induced oxidative damage in mice. J Pharm Pharmacol. 2005;57:135-143.
12. Hibasami H, Mitani A, Katsuzaki H, et al. Isolation of five types of flavonol from seabuckthorn (Hippophae rhamnoides) and induction of apoptosis by some of the flavonols in human promyelotic leukemia HL-60 cells. Int J Mol Med. 2005;15:805-809.
13. Yan X, Murphy BT, Hammond GB, et al. Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem. 2002;50:5844-5849.
14. Janisch KM, Williamson G, Needs P, et al. Properties of quercetin conjugates: modulation of LDL oxidation and binding to human serum albumin. Free Radic Res. 2004;38:877-884.
15. Negre-Salvayre A, Salvayre R. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Radic Biol Med. 1992;12:101-106.
16. Mehta JL, Li DY. Identification, regulation and function of LOX-1, a novel receptor for ox-LDL. J Am Coll Cardiol. 2002;39:1429-1435.
17. Mehta JL, Li DY. Inhibition of LOX-1 by statins may relate to up-regulation of eNOS. Biochem Biophys Res Commun. 2001;289:857-861.
18. Li DY, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation. 2000;101:2889-2895.
19. Li D, Mehta JL. Up-regulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscl Throm Vas. 2000;20:1116-1122.
20. Unger RE, Krump-Konvalinkova V, Peters K, et al. In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc Res. 2002;64:384-397.
21. Van Oost BA, Edgell CJ, Hay CW, et al. Isolation of human von Willebrand factor cDNA from the EA.hy926 cell line. Biochem Cell Biol. 1986;95:355-360.
22. Sternberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20968.
23. Brand-Williams W, Cuvelier ME, Berset C. Use of free radical method to evaluate antioxidant activity. Lebensmittel Wiss Technol. 1995;28:25-30.
24. Tennant JR. Evaluation of the trypan blue technique for determination of cell viability. Transplantation. 1964;2:685.
25. Artemis A, Dimitrios G, Orestes T. Superoxide anion generation by human peripheral blood mononuclear cells in response to prothymosin α. Arch Biochem Biophys. 1995;321:108-114.
26. Thomas T, Dimitris T. Growth hormone induces eNOS expression and nitric oxide release in a cultured human endothelial cell line. FEBS Lett. 2003;555:567-571.
27. Steffen Y, Schewe T, Sies H. Epicatechin protects endothelial cells against oxidized LDL and maintains NO synthase. Biochem Biophys Res Commun. 2005;331:1277-1283.
28. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995;57:791-804.
29. Benito S, Lopez D, Saiz MP, et al. A flavonoids-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol. 2002;135:910-916.
30. Sawa T, Nakao M, Akaike T, et al. Alkylperoxyl radical-scavenging activity of various flavonoids and other phenolic compounds: implications for the anti-tumor-promoter effect of vegetables. J Agri Food Chem. 1999;47:397-402.
31. Hanasaki Y, Ogawa S, Fukui S. The correlation between active oxygens scavenging and anti-oxidative effects of flavonoids. Free Radical Bio Med. 1994;16:845-850.
32. Gao Z, Huang K, Yang X, et al. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim Biophys Acta. 1999;1472:643-650.
33. Aoki M, Nata T, Morishita T, et al. Endothelial apoptosis induced by oxidative stress through activation of NF-kB: anti-apoptotic effect of antioxidant agents on endothelial cells. Hypertension. 2001;38:48-55.
34. Witztum JL, Steinberg D. Role of oxidized low-density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
35. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
36. Mehta JL, Li DY. Identification and auto-regulation of receptor for ox-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun. 1998;248:511-514.
37. Sawamura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997;386:73-77.
38. Li DY, Zhang YC, Philips MI, et al. Up-regulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin a type 1 receptor activation. Circ Res. 1999;84:1043-1049.
39. Hong C, Guowei H, Li L, et al. Protective effects of vitamin E on the vascular endothelial cells from oxidative injury by oxidized low-density lipoprotein in vitro. J Hygiene Res. 2003;32:576-577.
40. Cominacini L, Pasini AF, Garbin U, et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappa B through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000;275:12633-12638.
41. Erl W, Weber PC, Weber C. Monocytic cell adhesion to endothelial cells stimulated by oxidized low-density lipoprotein is mediated by distinct endothelial ligands. Atherosclerosis. 1998;136:297-303.
42. Keaney JF Jr, Gue Y, Cunningham D, et al. Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest. 1996;98:386-394.
43. Rubanye GM, Ho HE, Cantor EH, et al. Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun. 1991;181:1392-1397.
44. Geetha S, Ram MS, Singh V, et al. Anti-oxidant and immunomodulatory properties of seabuckthorn (Hippophae rhamnoides)-an in vitro study. J Ethnopharmacol. 2002;79:373-378.
45. Geetha S, Sai Ram M, Singh V, et al. Effect of seabuckthorn on sodium nitroprusside-induced cytotoxicity in murine macrophages. Biomed Pharmacother. 2002;56:463-467.
46. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-787.